A Review Of pentobarbital sodium use

A Review Of pentobarbital sodium use

Blog Article

Contraindicated (one)pentobarbital will reduce the level or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can result in diminished serum concentrations and lack of antimalarial efficacy

Contraindicated (one)pentobarbital will reduce the level or effect of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is responsible for the formation and elimination of cariprazine's Lively metabolites.

pentobarbital will lessen the extent or effect of cortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will reduce the extent or effect of eletriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital increases toxicity of buprenorphine, extended-performing injection by pharmacodynamic synergism. Modify Therapy/Check Carefully. Coadministration of buprenorphine and benzodiazepines or other CNS depressants boosts risk of adverse reactions together with overdose, respiratory depression, and Loss of life. Cessation of benzodiazepines or other CNS depressants is chosen generally.

pentobarbital will lower the extent or effect of estradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

Check Carefully (three)pentobarbital will lessen the level or effect of diazepam intranasal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Potent or moderate CYP3A4 inducers may enhance price of diazepam elimination; thus, efficacy of diazepam may very well be diminished.

pentobarbital will decrease the level or effect of almotriptan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the level or effect of artemether/lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration with potent CYP3A4 inducers can lead to diminished serum concentrations and lack of antimalarial efficacy

pentobarbital will reduce the level or effect of vincristine liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Mysterious.

Sodium valproate and valproic acid seem to lessen barbiturate metabolism; therefore, barbiturate blood stages should be monitored and acceptable dosage changes designed as indicated.

Keep an eye on Intently (1)pentobarbital will lessen the extent or effect of fentanyl by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of fentanyl with CYP3A4 inducers may lead to check here your decrease in fentanyl plasma concentrations, insufficient efficacy or, maybe, advancement of the withdrawal syndrome inside of a client who may have created Bodily dependence to fentanyl. Immediately after halting a CYP3A4 inducer, as the effects in the inducer decrease, the fentanyl plasma concentration will enhance which could increase or prolong the two the therapeutic and adverse effects.

TIME may possibly get payment for many hyperlinks to products and services on this Internet site. Offers can be topic to alter without observe.

pentobarbital will decrease the extent or effect of alfuzosin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unknown.